Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS

被引:242
作者
Alimonti, JB [1 ]
Ball, TB [1 ]
Fowke, KR [1 ]
机构
[1] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB R3E 0W3, Canada
关键词
D O I
10.1099/vir.0.19110-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
AIDS, caused by the retroviruses human immunodeficiency virus type 1 and type 2 (HIV-1 and HIV-2), has reached pandemic proportions. Therefore, it is critical to understand how HIV causes AIDS so that appropriate therapies can be formulated. Primarily, HIV infects and kills CD4(+) T lymphocytes, which function as regulators and amplifiers of the immune response. In the absence of effective anti-retroviral therapy, the hallmark decrease in CD4(+) T lymphocytes during AIDS results in a weakened immune system, impairing the body's ability to fight infections or certain cancers such that death eventually ensues. The major mechanism for CD4(+) T cell depletion is programmed cell death (apoptosis), which can be induced by HIV through multiple pathways. Death of HIV-infected cells can result from the propensity of infected lymphocytes to form short-lived syncytia or from an increased susceptibility of the cells to death. However, the apoptotic cells appear to be primarily uninfected bystander cells and are eradicated by two different mechanisms: either a Fas-mediated mechanism during activation-induced cell death (AICD), or as a result of HIV proteins (Tat, gp120, Nef, Vpu) released from infected cells stimulating apoptosis in uninfected bystander cells. There is also evidence that as AIDS progresses cytokine dysregulation occurs, and the overproduction of type-2 cytokines (IL-4, IL-10) increases susceptibility to ACID whereas type-1 cytokines (IL-12, IFN-gamma) may be protective. Clearly there are multiple causes of CD4(+) T lymphocyte apoptosis in AIDS and therapies that block or decrease that death could have significant clinical benefit.
引用
收藏
页码:1649 / 1661
页数:13
相关论文
共 152 条
  • [21] Vpu increases susceptibility of human immunodeficiency virus type 1 infected cells to Fas killing
    Casella, CR
    Rapaport, EL
    Finkel, TH
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (01) : 92 - 100
  • [22] CHANAKYA HN, 1997, BIOENERGY NEWS, V1, P11
  • [23] HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim
    Chen, D
    Wang, M
    Zhou, S
    Zhou, Q
    [J]. EMBO JOURNAL, 2002, 21 (24) : 6801 - 6810
  • [24] Chougnet C, 1998, EUR J IMMUNOL, V28, P646, DOI 10.1002/(SICI)1521-4141(199802)28:02<646::AID-IMMU646>3.0.CO
  • [25] 2-6
  • [26] Cicala C, 1999, J IMMUNOL, V163, P420
  • [27] HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4+ T cells
    Cicala, C
    Arthos, J
    Rubbert, A
    Selig, S
    Wildt, K
    Cohen, OJ
    Fauci, AS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (03) : 1178 - 1183
  • [28] HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION
    CLARK, SJ
    SAAG, MS
    DECKER, WD
    CAMPBELLHILL, S
    ROBERSON, JL
    VELDKAMP, PJ
    KAPPES, JC
    HAHN, BH
    SHAW, GM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) : 954 - 960
  • [29] Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin
    Clerici, M
    Sarin, A
    Berzofsky, JA
    Landay, AL
    Kessler, HA
    Hashemi, F
    Hendrix, CW
    Blatt, SP
    Rusnak, J
    Dolan, MJ
    Coffman, RL
    Henkart, PA
    Shearer, GM
    [J]. AIDS, 1996, 10 (06) : 603 - 611
  • [30] THE TH1-TH2 HYPOTHESIS OF HIV-INFECTION - NEW INSIGHTS
    CLERICI, M
    SHEARER, GM
    [J]. IMMUNOLOGY TODAY, 1994, 15 (12): : 575 - 581